1 / 37

Benign Anorectal: Abscess and Fistula

Benign Anorectal: Abscess and Fistula. Seema Izfar, MD. 12/21/11. Benign Anorectal: Abscess and Fistula. anorectal abscess and fistula-in-ano represent different stages of the same disease the abscess represents the acute inflammatory event the fistula represents the chronic process.

lilith
Download Presentation

Benign Anorectal: Abscess and Fistula

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Benign Anorectal: Abscess and Fistula • Seema Izfar, MD 12/21/11

  2. Benign Anorectal: Abscess and Fistula • anorectal abscess and fistula-in-ano represent different stages of the same disease • the abscess represents the acute inflammatory event • the fistula represents the chronic process

  3. Benign Anorectal: Abscess and Fistula • diagnosis and treatment requires in-depth understanding of anorectal anatomy and spaces

  4. Benign Anorectal: Abscess and Fistula • at the dentate line, the ducts of the anal glands empty into anal crypts • 80% are submucosal, 8% extend to internal sphincter, 8% to the conjoined longitudinal muscle, 2% intersphincteric, 1% penetrate internal sphincter • 90% of anorectal abscess result from crytogladular infection • Parks cryptoglandular theory - obstruction of anal glands leads to stasis and infection

  5. Abscess • classified by location: perianal, ischioanal, intersphincteric, supralevator • perianal abscess most common, supralevator most rare • pain, swelling, fever hallmark symptoms • supralevator abscess may have gluteal pain • rectal pain with urinary symptoms - possibly indicate intersphincteric or supralevator abscess

  6. Abscess - Etiology • nonspecific cryptoglandular (90%) • specific causes: • inflammatory bowel disease, • specific infection, ie TB, actinomycosis, lymphogranuloma venereum, • trauma or foreign body • surgery (episiotomy, hemorrhoidectomy, prostatectomy), • malignancy - carcinoma, lymphoma, radiation-related

  7. Abscess - Treatment • exam under anesthesia for pain out of proportion to exam • incision and drainage - trim edges to prevent coaptation • I&D of supralevator abscess: • depends on location - intersphincteric origin then divide internal sphincter and drain into rectum; if arises from ischianal abscess can be drained through perineal skin

  8. Abscess

  9. Abscess

  10. Abscess - Treatment • catheter drainage: stab incision to drain pus, mushroom catheter in cavity to drain pus • make stab incision as close as possible to anus • size and length of catheter should correspond to abscess cavity

  11. Abscess - Treatment • primary fistulotomy • may be easier to identify tract • eliminates source of infection • decreases recurrence/need for reoperation • downsides: false passage formation with acute inflammation, 30-50% of those with abscess likely won’t develop a fistula, need for anesthesia vs. local for I & D

  12. Abscess - Antibiotics • little or no role except in case of valvular heart disease, prosthetic devices, severe cellulitis, diabetes, immunosuppression

  13. Abscess - Complications • Recurrence • recurrence in as many as 89% of pts • Extra-anal causes • should be evaluated for recurrent disease (hidradenitis suppurativa, Crohn’s) • Incontinence • iatrogenic (superficial external sphincter), inappropriate wound care (excessive scarring from prolonged packing)

  14. Abscess - Complications • can result in necrotizing anorectal infection (rare) • resuscitation, IV abx, wide debridement to healthy tissue • need for colostomy debatable - recommended if sphincter muscle is grossly infected, immunocompromised, rectal or colonic involvement/perforation • reexamination under anesthesia • HBO - 100% O2 at 3atm over 2 hrs - promote leukocyte phagocytic function and fibroblast proliferation

  15. Anal Infection and Hematologic Diseases • anorectal suppuration with acute leukemia with mortality 45-78% • neutrophil count <500 with 11% incidence of anorectal abscess • most important prognostic factor - # days of neutropenia • presenting symptoms: fever, pain, urinary retention • antibiotics vs I & D if fluctuance, sepsis, or progression of soft tissue infection after antibiotics trial

  16. Anal Infection & HIV • HIV+ pts have increased risk of perianal sepsis • can be associated with in situ neoplasia • surgery + antibiotics 2/2 immunosuppression • make incison site small bc pts at risk for poor wound healing

  17. Fistula-in-ano • abnormal communication between any two epithelium-lined surfaces • Parks classification:

  18. Intersphincteric Fistula-in-ano • most common type of fistula - 70% • results from perianal abscess • variations: • simple low tract • high tract with rectal opening or blind tract • extrarectal extension • pelvic disease tracking

  19. Transsphincteric Fistula • approx 23% fistulas • results from ischioanal absecesses • rectovaginal fistula is a form of transsphincteric fistula • operative mgt with setons if sphincter preservation in question

  20. Suprasphincteric Fistula • 5% of fistulas • result from supralevator abscesses • tract arises from intersphincteric abscess, travels above puborectalis, then downward lateral to external sphincters in ischioanal space

  21. Extrasphincteric Fistula • 2% of fistulas - rarest form • from rectum above the levators, through them, to the perianal skin • trauma, foreign body, Crohn’s carcinoma • most common cause is iatrogenic from probing during fistulotomy surgery

  22. Fistula-in-ano: Physical Examination • Goodsall’s rule: • transverse line across the perineum - • posterior external openings have internal openings in the posterior midline • anterior external openings have tract radially toward the nearest crypt • greater distance from anal margin with more variability • more accurate rule for posterior fistulas

  23. Fistula-in-ano: Treatment • eliminate fistula, • prevent recurrence, • preserve sphincter function

  24. Fistula-in-ano: Treatment • identification of internal opening • passage of probe • injection of dye, milk, or hydrogen peroxide • following granulation in fistula tract • noting puckering of crypt with traction on fistula tract

  25. Fistula-in-ano: Operative Management • Lay-open technique: identification of tract with unroofing tract +/- marsupialization • appropriate for simple interspincteric and low transsphincteric

  26. Fistula-in-ano: Operative Management • Seton - placement of non-absorbable suture material in fistula tract • indications for setons: • promote fibrosis around fistula tract that encircles entire sphincter mechanism • mark the site of fistula in massive anorectal sepsis • anterior high transsphincteric fistulas in women • HIV pts with poor wound healing and high transsphincteric fistulas • Crohn’s • any time continence is questioned

  27. Fistula-in-ano: Operative Management • high-transphincteric fistulas can be treated with combination lay-open technique and seton placement - division of internal sphincter to level of external opening and then seton placement • cutting setons can convert high fistulas to low fistulas • second-stage fistulotomy ~ 8 wks later

  28. Fistula-in-ano: Operative Management • suprasphincteric fistula - tract involves external sphincter and puborectalis - • can manage with division of internal sphincter and superficial external sphincter with seton around remaining ES • or internal sphincterotomy, seton, opening of fistula tracts without division of external sphincter

  29. Fistula-in-ano: Operative Management • Anorectal Advancement Flap • internal opening closed with absorbable suture, full-thickness flap of rectal mucosa/submucosa/IAS raised - adv 1 cm beyond internal opening • base of the flap should be twice the width of the apex • pros: reduction in healing time, reduced pain, little potential damage to sphincters, lack of deformity to anal canal • poor outcomes in Crohn’s, pts on steroids, smokers, o/w success reported in up to 90% of pts

  30. Fistula-in-ano: Operative Management • Fibrin Glue - used in conjuntion with AAF or alone • technique: internal and external openings identified, tract curetted, fistula tract injected through connector from external opening until glue visible in internal opening, slowly withdrawn • can be repeated several times without compromising continence

  31. Fistula-in-ano: Operative Management • Fibrin Glue - Followup: • short-term follow-up with good success 70-80% • longer follow-up with success falling to 60% and even 14% in pts with complex anal fistulas

  32. Fistula-in-ano: Operative Management • bioprosthetic fistula plug made from surgisis • technique - identification of internal and external opening with placement of plug over probe using suture similar to seton placement • plug secured at primary opening using absorbable suture

  33. Fistula-in-ano: Operative Management • technique works best with long tracts without active inflammation or sepsis • short-term follow up (3months) with higher success rate for Crohn’s fistulas when compared to fibrin glue • long-term follow up - high failure rate

  34. Crohn’s and Anal Fistulas • the most common perianal manifestation and occur in 6-34% Crohn’s pts - pts with colonic Crohn’s with higher incidence, rectal Crohn’s with 100% fistula formation • conservative approach to treatment as 38% heal without surgery

  35. Crohn’s and Anal Fistulas • medications for treatment: cipro/flagyl, immunomodulators (steroids, 6MP, azathioprine, infliximab) • 6-MP and azathioprine only effective in 1/3 pts with fistulizing Crohn’s • Infliximab associated with 62% reduction • combination 6MP and infliximab may prolong effect of treatment • selective seton placement with infliximab + maintenance med with healing in 67%

  36. Crohn’s and Anal Fistulas • operative intervention: seton placement, rectal advancement flap if rectal-sparing, poss fibrin glue/plug • avoid cutting sphincter - incontinence reported in pts with Crohn’s proctitis even without anal surgery

More Related